These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8093295)

  • 21. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell depletion in unrelated bone marrow transplantation.
    Tricot G
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):26-31; discussion 31-2. PubMed ID: 1615342
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
    Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
    N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell depletion in bone marrow transplantation for leukemia: current results and future directions.
    Butturini A; Gale RP
    Bone Marrow Transplant; 1988 May; 3(3):185-92. PubMed ID: 3048485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of four different protocols for prophylaxis against graft-versus-host disease.
    Tollemar J; Ringdén O; Bäckman L; Janossy G; Lönnqvist B; Markling L; Philstedt P; Sundberg B
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3008-10. PubMed ID: 2650414
    [No Abstract]   [Full Text] [Related]  

  • 26. Bone marrow transplantation for leukemia: effects of T lymphocyte depletion of donor bone marrow.
    Champlin R
    Transplant Proc; 1987 Feb; 19(1 Pt 1):157-9. PubMed ID: 3274769
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.
    Jansen J; Hanks S; English D; Karaffa R; Akard L
    Prog Clin Biol Res; 1992; 377():405-10. PubMed ID: 1438437
    [No Abstract]   [Full Text] [Related]  

  • 28. T-cell depletion to prevent GVHD after unrelated-donor marrow transplantation.
    Locatelli F; De Stefano P
    Lancet; 2005 Aug 27-Sep 2; 366(9487):692-4. PubMed ID: 16125569
    [No Abstract]   [Full Text] [Related]  

  • 29. Graft versus host disease prophylaxis today.
    Martelli MF; Aversa F
    Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726
    [No Abstract]   [Full Text] [Related]  

  • 30. Mixed chimerism after allogeneic bone marrow transplantation for leukemias.
    Bertheas MF; Lafage M; Blaise D; Stoppa AM; Viens P; Mannoni P; Maraninchi D
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():61-3. PubMed ID: 2390641
    [No Abstract]   [Full Text] [Related]  

  • 31. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [T-cell depletion today: pros and cons].
    Martelli MF; Aversa F
    Haematologica; 1989 Oct; 74(5 Suppl):405-17. PubMed ID: 2512224
    [No Abstract]   [Full Text] [Related]  

  • 33. T-cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment, and graft-versus-leukemia.
    Champlin R
    J Hematother; 1993; 2(1):27-42. PubMed ID: 7921964
    [No Abstract]   [Full Text] [Related]  

  • 34. [T cell depletion for allogeneic bone marrow transplantation].
    Morishima Y
    Nihon Rinsho; 1990 Sep; 48(9):1971-6. PubMed ID: 2232199
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial.
    Wagner JE; Thompson JS; Carter SL; Kernan NA;
    Lancet; 2005 Aug 27-Sep 2; 366(9487):733-41. PubMed ID: 16125590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of the graft-versus-host disease by T-cell depletion in allogenic bone marrow transplantation].
    Hervé P
    Presse Med; 1987 Nov; 16(40):2019-25. PubMed ID: 2962175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.
    Ringdén O; Pihlstedt P; Markling L; Aschan J; Båryd I; Ljungman P; Lönnqvist B; Tollemar J; Janossy G; Sundberg B
    Bone Marrow Transplant; 1991 Mar; 7(3):221-6. PubMed ID: 2059758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post transplant lymphoproliferative disorders following reduced intensity conditioning with in vivo T cell depletion.
    Peggs KS; Banerjee L; Thomson K; Mackinnon S
    Bone Marrow Transplant; 2003 Apr; 31(8):725-6; author reply 727. PubMed ID: 12822577
    [No Abstract]   [Full Text] [Related]  

  • 39. [In vitro manipulation of bone marrow cells for bone marrow transplantation].
    Morishima Y
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3034-43. PubMed ID: 3056275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.